Our work is a critical part of the vaccine development pipeline. Our efforts ensure that only the most promising vaccine candidates are moved through to trials on humans.
We're working on the development, testing and manufacture of a vaccine for the novel coronavirus responsible for causing COVID-19.
We worked with vaccine developers to produce small volumes of candidate vaccines to the highest quality standards, for use in trials. If successful, our manufacturing process can be scaled with an industry partner.
The Coalition for Epidemic Preparedness Innovations (CEPI) engaged us in January 2020 to undertake critical new research on SARS-CoV-2, the virus that causes COVID-19, at the Australian Centre for Disease Preparedness, our high-containment biosecurity facility in Geelong.
We are also working with the research sector and industry regarding the preclinical evaluation of therapeutics, to see if they are effective against COVID-19.
Enter a valid email address, for example jane.doe@csiro.au.
First name must be filled in
We'll need to know what you want to contact us about so we can give you an answer.
Sorry, an error has occured, please try again.
We have received your enquiry and will reply soon.
